Page 74 - 74_01
P. 74

JUAN-RAMÓN LACADENA CALERO  AN. R. ACAD. NAC. FARM.

(12)  ROBERTSON, E.; BRADLEY, A.; KUEHN, M.; EVANS, M. J. (1986): Gefrm-line trans-
(13)  mission of genes introduced into cultured pluripotential cells by retroviral
(14)  vector. Nature. 323: 445-448.
(15)  KUEHN, M. R.; BRADLEY, A.; ROBERTSON, E.; EVANS, M. J. (1987): A potential
(16)  animal model for Lesch-Nyhan syndrome through introduction of HPRT mu-
(17)  tations into mice. Nature. 326: 295-298.
(18)  HOOPER, M.; HARDY, K.; HANDYSIDE, A.; HUNTER, S.; MONK, M. (1987): HPRT-
(19)  deficient (Lesch-Nyhan) mouse embryos derived from germline colonization
(20)  by cultured cells. Nature. 326: 292-295.
(21)  DOETSCHMAN, T.; GREGG, R. G.; MAEDA, N.; HOOPER, M. L.; MELTON, D. W.;
(22)  THOMPSON, S.; SMITHIES, O. (1987): Targeted correction of a mutant HPRT
      gene in mouse embryonic stem cells. Nature. 330: 576-578.
(23)  THOMAS, K. R.; CAPECCHI, M. R. (1987): Site-directed mutagenesis by gene
(24)  targeting in mouse embryo-derived stem cells. Cell. 51: 503-512.
(25)  MANSOUR, S. L.; THOMAS, K. R.; CAPECCHI, M. R. (1988): Disruption of the
      proto-oncogene int-2 in mouse-embryo-derived stem cells: a general strategy
(26)  for targeting mutations to non-selectable genes. Nature. 336: 348-352.
      CLARKE, L. L.; GRUBB, B. R.; GABRIEL, S. E.; SMITHIES, O.; KOLLER, B. H.;
      BOUCHER, R. C. (1992): Defective epithelial chloride transport in a gene-tar-
      geted mouse model of cystic fibrosis. Science. 257: 1125-1128.
      SNOUWAERT, J. N.; BRIGMAN, K. K.; LATOUR, A. M.; MALOUF, N. N.; BOUCHER, R.
      C.; SMITHIES, O., et al. (1992): An animal model for cystic fibrosis made by
      gene-targeting. Science. 257: 1083-1088.
      SMITHIES, O.; MAEDA, N. (1995): Gene targeting approaches to complex genetic
      diseases: Atherosclerosis and essential hypertension. Proc. Nat. Acad. Sci. 92:
      5266-5272.
      THOMSON, J. A.; ITSKOVITZ-ELDOR, J.; SHAPIRO, S. S.; WAKNITZ, M. A.; SWIERGIEL,
      J. J.; MARSHALL, V. S.; JONES, J. M. (1998): Embryonic stem cells derived from
      human blastocystes. Science. 282: 1145-1147.
      YU, J.; VODYANIK, M. A.; SMUGA-OTTO, K.; ANTOSIEWICZ-BOURGET, J.; FRANE, J. L.;
      TIAN, S.; NIE, J.; JONSDOTTIR, G. A.; RUOTTI, V.; STEWART, R.; SLUKVIN, I. I.;
      THOMSON, J. A. (2007): Induced pluripotent stem cell derived from human
      somatic cells. Science doi:10.1126/science.1151526.
      TAKAHASHI, K., et al. (2007): Cell doi:10.1016/j.cell.2007.11.019.
      TAKAHASHI, K.; YAMANAKA, S. (2006): Induction of pluripotent stem cells from
      mouse embryonic and adult fibtoblast cultures by defined factors. Cell. 126:
      663-676.
      HANNA, J.; WERNING, M.; MARKOULAKI, S.; SUN, CH-W.; MEISSNER, A.; CASSADI, J.
      P.; BEARD, C.; BRAMBRINK, T.; WU, L-CH.; TOWNES, T. M.; JAENISCH, R. (2007):
      Treatment of sickle cell anemia mouse model with iPS cells generated from
      autologous skin. Science DOI: 10.1126/science.1152092.
      BYRNE, J. A.; PEDERSEN, D. A.; CLEPPER, L. L.; NELSON, M.; SANGER, W. G.;
      GOKHALE, S.; WOLF, D. P.; MITALIPOV, S. M. (2007): Producing primate embr-
      yonic stem cells by somatic cell nuclear transfer. Nature doi:10.1038/nature
      06357.

78
   69   70   71   72   73   74   75   76   77   78   79